Unlock instant, AI-driven research and patent intelligence for your innovation.

Indole compound and its application and preparation method

A compound and indole technology, applied in the field of medicine, can solve the problems of lack of effective treatment of tumors and anti-tumor drugs that cannot meet the treatment requirements

Active Publication Date: 2021-07-06
GUANGZHOU MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the anti-tumor drugs currently used in clinical practice are far from meeting the requirements of treatment, and there is still a lack of effective drugs for the treatment of tumors.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Indole compound and its application and preparation method
  • Indole compound and its application and preparation method
  • Indole compound and its application and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0096] The synthesis of embodiment 1 compound 3a

[0097]

[0098]Take a 100mL reaction bottle, evacuate it, fill it with nitrogen, and repeat the operation three times, then add 2a (421mg, 3.6mmol) to the bottle, then add DMF (30mL), stir at 0°C, and slowly add NaH in batches (60% distribution in mineral oil, 180 mg, 4.5 mmol) into the stirred solution. After stirring at 0°C for 30 minutes, 1a (590mg, 3.0mmol) was added, and the reaction was stirred at room temperature for 20 hours, then 100mL of water was added to quench the reaction, extracted with ethyl acetate (50mL×3), and the organic phase was washed with Dry over anhydrous sodium sulfate. After filtration, the filtrate was spin-dried (the solvent was evaporated under reduced pressure), and separated by silica gel column chromatography (petroleum ether / ethyl acetate=5 / 1) to obtain the yellow solid product 3a (749 mg, 90%). The characterization data of this compound are as follows: 1 H NMR (400MHz, CDCl 3 )δ=9.18(...

Embodiment 2

[0099] The synthesis of embodiment 2 compound 3b

[0100]

[0101] According to the method described in Example 1, 2a (421mg, 3.6mmol) was added to a 100mL reaction flask under nitrogen atmosphere, then DMF (30mL) was added, stirred at 0°C, and NaH was slowly added in batches (in Distribute 60% in mineral oil, 180 mg, 4.5 mmol) into the stirred solution. After stirring at 0°C for 30 minutes, 1b (497mg, 3.0mmol) was added, and the reaction was stirred at room temperature for 20 hours, then 100mL of water was added to quench the reaction, extracted with ethyl acetate (50mL×4), and the organic phase was washed with Dry over anhydrous sodium sulfate. It was filtered, spin-dried, and separated by silica gel column chromatography to obtain product 3b (523 mg, 70%) as a yellow solid. The characterization data of this compound are as follows: 1 H NMR (400MHz, CDCl 3 )δ=9.11(d, J=2.9Hz, 1H), 9.03(d, J=8.3Hz, 1H), 8.79(s, 1H), 7.86(s, 1H), 7.62(d, J=7.6Hz, 1H), 7.36 (t, J = 7.7H...

Embodiment 3

[0102] The synthesis of embodiment 3 compound 3c

[0103]

[0104] According to the method described in Example 1, 2a (421mg, 3.6mmol) was added to a 100mL reaction flask under a nitrogen atmosphere, and then DMF (30mL) was added, stirred at 0°C, and NaH was slowly added in batches (in Distribute 60% in mineral oil, 180 mg, 4.5 mmol) into the stirred solution. After stirring at 0°C for 30 minutes, 1c (732 mg, 3 mmol) was added, and the reaction was stirred at room temperature for 20 hours to obtain the product 3c (580 mg, 60%) as a white solid. The characterization data of this compound are as follows: 1 H NMR (400MHz, CDCl 3 )δ=9.17(d, J=3.7Hz, 1H), 9.09(d, J=8.5Hz, 1H), 8.86(s, 1H), 7.94(s, 1H), 7.65(d, J=7.7Hz, 1H), 7.40–7.29 (m, 7H), 6.80 (d, J=3.6Hz, 1H). 13 CNMR (100MHz, CDCl 3 ) δ = 152.8, 152.3, 150.0, 142.3, 136.2, 135.3, 130.8, 129.2, 128.7, 128.6, 127.9, 124.0, 123.0, 122.3, 120.9, 117.4, 108.6, 47.4. HR-MS(ESI)m / z calcd for C 20 h 16 N 5 [M+H] + 326.14...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to indole compound and its application and preparation method. The structural formula of the indole compound is shown in formula (I). The novel indole compound of the present invention has an inhibitory effect on the lumen formation of umbilical vein endothelial cells (HUVEC), and can be applied to the treatment of pathological angiogenesis-related diseases, especially to the prevention and treatment of tumors and rheumatoid arthritis. It has great application value.

Description

technical field [0001] The invention relates to the field of medicine, in particular to an indole compound and its application and preparation method. Background technique [0002] Malignant tumors are one of the diseases that pose a great threat to human health. According to relevant statistics from the China Cancer Management Center, the incidence and death of malignant tumors in China have shown an upward trend in recent years. According to the 2018 global cancer statistics report of the official journal of the American Cancer Society "Journal of Cancer for Clinicians", the cancers with the largest number of new cases and deaths are lung cancer, breast cancer, prostate cancer, colon cancer, non-melanoma of the skin, gastric cancer, Liver cancer, rectal cancer, etc. Clinically, drug therapy is still the main treatment for tumors. However, the anti-tumor drugs currently used in clinical practice are far from meeting the requirements of treatment, and there is still a lack...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D473/34C07D519/00C07F5/02A61P35/00A61P35/02A61P19/02A61P29/00A61K31/52A61K31/69
CPCA61P19/02A61P29/00A61P35/00A61P35/02C07D473/34C07D519/00C07F5/025
Inventor 阮志雄余细勇王玉青雷雪萍徐中楠
Owner GUANGZHOU MEDICAL UNIV